Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial

por Aldrich, Cassandra, Leroux–Roels, Isabel, Huang, Katell Bidet, Bica, Mihai Alexandru, Loeliger, Edde, Schoenborn-Kellenberger, Oliver, Walz, Lisa, Leroux-Roels, Geert, von Sonnenburg, Frank, Oostvogels, Lidia
Publicado 2021

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques

por Valentin, Antonio, Bergamaschi, Cristina, Rosati, Margherita, Angel, Matthew, Burns, Robert, Agarwal, Mahesh, Gergen, Janina, Petsch, Benjamin, Oostvogels, Lidia, Loeliger, Edde, Chew, Kara W., Deeks, Steven G., Mullins, James I., Pavlakis, George N., Felber, Barbara K.
Publicado 2022